Home › Occupations › Medical Scientists, Except Epidemiologists › Buffalo, NY
Medical Scientists, Except Epidemiologists in Buffalo, NY: H-1B salaries
119 labor condition applications for this occupation with a work site in Buffalo, NY. Median offered base salary $65,000; middle half $57,102–$75,000.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $59,756 |
| Level II (qualified) | $82,650 |
| Level III (experienced) | $117,195 |
| Level IV (fully competent) | $181,600 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| Health Research Inc. - Roswell Park Division | 62 | $65,800 |
| Research Foundation of Suny at Buffalo | 39 | $57,346 |
| Roswell Park Cancer Institute | 8 | $135,000 |
| Research Foundation for the State University of New York | 3 | $62,296 |
| State University of New York at Buffalo | 2 | $48,150 |
| Simulations Plus, Inc. | 1 | $125,000 |
| Merck Sharp & Dohme LLC | 1 | $181,600 |
| Truvai Biosciences, LLC | 1 | $115,000 |
| Solstice Advanced Materials US, Inc. | 1 | $135,000 |
| Certara USA Inc. | 1 | $117,195 |
Job titles
- Research Scientist25
- Postdoctoral Associate16
- Research Affiliate (Post-Doctoral)12
- Research Associate11
- Affiliate Member11
- HRI Scientist9
- Senior Research Specialist9
- Assistant Member (Clinical Research)6
- Research Affiliate (Post-Doc)5
- Research Support Specialist2
- Translational Research Scientist2
- Research Technologist1
- Pharmacometrician1
- Mass Spectrometry Scientist1
- Senior Research Associate1
H-1B sponsors in Buffalo, NY →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).